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  Effect of tiemonium iodide （Visceralgine） on normal ureteral contractile activity was
studied on 15 human subjects （25 ureters） by means of strain gauge manometer． The clinical
effect， especially， of subsiding pain by this agent was also studied in 41 urological patients．
  For the former study， 5 mg （8 cases） or 10mg （7 cases） of Visceralgine were administered
intramuscularly． The following results were obtained．
  ユ） In 3 cases（one with 5 mg；two with 10 mg）， irregular spastic contraction of the
u．reter was released， resulting in normal pattern （Fig． 1， 4 and 5）．
  2） ln 2 cases （both with 10 mg）， spastic contractile waves became more regular than
before．
  3） ln 2 cases （both with ／0mg）， ureteral contraction stopped for several minutes after
administration， followed by accelerated contractions， rather （Fig． 6 and 7）．
  Efilcacy rate of Visceralgine for urological use was found to be approximately 70％ in
1皿ost Qf the reports．
  According to our study on 4！ patients， the ethcacy rate of this drug was 70．7％．
  Visceralgine was particularly effective for 62，5％ of vesico－urethral irritability．
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Fig． 6 Case 13：4ml of Visceralgine was intramuscularly injected．
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逆行性腎孟撮影後の痙癌．F
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膀胱・尿道刺激症状！F
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